Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
02/22/2011 | US7892796 Solid support assay systems and methods utilizing non-standard bases |
02/22/2011 | US7892794 Using apparatus which generates alternating electric pulses to isolate preferential bioparticles from gas; utilizing cyclic replication to amplify recovered biopolymers |
02/22/2011 | US7892791 Fluorescent protein and chromoprotein |
02/22/2011 | US7892785 In vito translation o proteins; obtain nucleotide sequences, incubate with reaction mixtures, translate, recover proteins |
02/22/2011 | US7892782 Screening process for antibacterial agents |
02/22/2011 | US7892775 Fluorescence assay for kinase activity |
02/22/2011 | US7892774 Diagnostic method for determining the susceptibility to delivery and reagent kit for use therefor |
02/22/2011 | US7892773 Expression vector comprising nucleotide sequences coding homeobox transcriptional regulator gene for identifying modulators for treatment and prevention of cell proliferative disorders of urogenital system |
02/22/2011 | US7892770 Monoclonal antibody which binds cMet (HGFR) in formalin-fixed and paraffin-embedded tissues and related methods |
02/22/2011 | US7892769 Processing of EphA4 polypeptide by γ-secretase activity |
02/22/2011 | US7892768 Using presence of collagen IX alpha-1chain polypeptide fragments as diagnostic indicator of arthritic, bone, cardiovascular and/or inflammatory disorders |
02/22/2011 | US7892767 Phosphospecific chemokine receptor antibodies |
02/22/2011 | US7892766 Continuous flow chamber device for separation, concentration, and/or purification of cells |
02/22/2011 | US7892765 Methods of screening modulators of hetero-oligomeric sweet taste receptors |
02/22/2011 | US7892764 Inhibiting acid sensing ion channel 1a (ASIC1a); epilepsy; using PcTX1 or peptide derivative and/or amiloride or derivative |
02/22/2011 | US7892763 Multi-stage nutrigenomic diagnostic food sensitivity testing in animals |
02/22/2011 | US7892762 Method for diagnosing irritable bowel syndrome and monitoring inflammatory bowel disease |
02/22/2011 | US7892761 Protein markers for diagnosing stomach cancer and the diagnostic kit using them |
02/22/2011 | US7892760 Lung cancer markers, and uses thereof |
02/22/2011 | US7892759 Enhanced sensitivity of a cantilever sensor via specific bindings |
02/22/2011 | US7892758 Use of N-myristoyltransferase on non-tumor tissue for cancer diagnosis |
02/22/2011 | US7892757 Immunochemical determination method and determination reagent for cytochrome c |
02/22/2011 | US7892756 Human salty taste receptor and methods of modulating salty taste perception |
02/22/2011 | US7892755 Of nitroquinoxaline-2,3-diones or ellagic acid as binding ligands for G protein coupled receptor 35; antidiabetic agents; anticarcinogenic agents for gastrointestinal cancer; obesity, immunotherapy |
02/22/2011 | US7892754 Hepatitis B virus pre-S1 derived synthetic polypeptides and uses thereof |
02/22/2011 | US7892753 Diagnostic and therapeutic applications of soluble LHCGR protein |
02/22/2011 | US7892752 Glycosylation markers for cancer diagnosing and monitoring |
02/22/2011 | US7892751 Using antiphospholipid autoantibody expression profile as evaluative tool in screening for alzheimer's disease |
02/22/2011 | US7892750 Cathepsin E as a marker of colon cancer |
02/22/2011 | US7892749 Methods for differentiating and monitoring parathyroid and bone status related diseases |
02/22/2011 | US7892748 Reagent for detecting an analyte |
02/22/2011 | US7892730 Nucleotide sequences coding polypeptide for use in the treatment of and detection of cancer |
02/22/2011 | US7892729 Universal and differential serologic assay for swine influenza virus |
02/22/2011 | US7892727 Chemokine-binding protein and methods of use |
02/22/2011 | US7892561 Neutralizing GDF8 epitope-based growth enhancing vaccine |
02/22/2011 | US7892559 Major histocompatibility complex class I restricted epitope peptide for use in diagnosis, prevention and treament of cell proliferative disorders; antitumor agents |
02/22/2011 | US7892557 Peptide mimotopes of mycobacterial mannosylated lipoglycans and uses thereof |
02/22/2011 | US7892551 Antibody kit for enumeration of CD4+ lymphocytes |
02/22/2011 | US7892548 121P1F1: a tissue specific protein highly expressed in various cancers |
02/22/2011 | US7892544 Humanized anti-beta-amyloid antibody |
02/22/2011 | US7892539 Modulation of an innate immune response by altering TRIAL-R signaling |
02/22/2011 | US7892493 Fluid sample transport device with reduced dead volume for processing, controlling and/or detecting a fluid sample |
02/22/2011 | US7892415 Mesoporous platinum electrode and method for detecting biochemical substrate using the mesoporous platinum electrode |
02/22/2011 | US7891233 Blast movement monitor |
02/22/2011 | CA2525240C Detection of biochemical interactions on a biosensor using tunable filters and tunable lasers |
02/22/2011 | CA2456829C Reference control for high-sensitivity c-reactive protein testing |
02/22/2011 | CA2455932C Assay electrodes having immobilized lipid/protein layers, methods of making the same and methods of using the same for luminescence test measurements |
02/22/2011 | CA2441566C Blood cell production via activation of the hemoglobin scavenger receptor |
02/22/2011 | CA2435503C Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
02/22/2011 | CA2433281C Rapid and quantitative proteome analysis and related methods |
02/22/2011 | CA2422765C Assay method and kit therefor |
02/22/2011 | CA2410193C Neuronal serine-threonine protein kinase |
02/22/2011 | CA2409208C Method for examining wt1-related disease |
02/22/2011 | CA2404429C Malaria plasmodium antigen polypeptide se36, method of purifying the same and vaccine and diagnostic with the use of the thus obtained antigen |
02/22/2011 | CA2253875C Early detection of lysosomal storage disorders |
02/17/2011 | WO2011020079A1 Antibodies against human respiratory syncytial virus (rsv) and methods of use |
02/17/2011 | WO2011020069A1 Bacterial strain identification method and system |
02/17/2011 | WO2011020011A2 Droplet actuator and droplet-based techniques |
02/17/2011 | WO2011019980A1 Novel role of alpha-galactosidase activity as a biomarker in kidney disease |
02/17/2011 | WO2011019932A2 Compositions and methods for the therapy and diagnosis of influenza |
02/17/2011 | WO2011019929A1 Methods of diagnosing and treating autism |
02/17/2011 | WO2011019864A2 Methods for mobile zinc measurement |
02/17/2011 | WO2011019822A2 Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products |
02/17/2011 | WO2011019807A2 Measurement of mitochondrial membrane potential to assess organ dysfunction |
02/17/2011 | WO2011019787A1 Apparatus to determine coefficient of friction |
02/17/2011 | WO2011019558A1 Methods to measure dissociation rates for ligands that form reversible covalent bonds |
02/17/2011 | WO2011019556A1 CO-CRYSTALLIZATION OF ERR-A α WITH A LIGAND THAT FORMS A REVERSIBLE CONVALENT BOND |
02/17/2011 | WO2011019516A2 Microfluidic diagnostic device |
02/17/2011 | WO2011019363A1 Detection of hepatic insulin resistance |
02/17/2011 | WO2011019286A1 Method of detecting pneumocandin compounds |
02/17/2011 | WO2011019082A1 Method for measuring autophagy |
02/17/2011 | WO2011019074A1 Nucleic acid that controls fibrosis of cells or organs |
02/17/2011 | WO2011019072A1 Biomarker for depression, method for measuring a biomarker for depression, computer program, and recording medium |
02/17/2011 | WO2011019068A1 Urinary function measuring device for animal and urinary function measuring method for animal |
02/17/2011 | WO2011019030A1 Coating apparatus and liquid substance coating method |
02/17/2011 | WO2011018710A2 Biological components within the cerebrospinal fluid |
02/17/2011 | WO2011018669A2 A condenser for breath condensate |
02/17/2011 | WO2011018667A1 Endonuclease g as target for hypertension and hypertrophy associated diseases |
02/17/2011 | WO2011018665A1 Complexing system |
02/17/2011 | WO2011018618A2 Assay device |
02/17/2011 | WO2011018613A1 Functionalisation of solid substrates |
02/17/2011 | WO2011018611A1 Reversible covalent linkage of functional molecules |
02/17/2011 | WO2011018586A2 Method for predetermining the binding of a given compound to a membrane receptor |
02/17/2011 | WO2011018451A1 Nanoparticle screening methods employing insects with blood brain barrier |
02/17/2011 | WO2011018450A1 Insect-based model for pharmaco-kinetic studies |
02/17/2011 | WO2011018449A1 Methods employing insect models for determining intestinal absorption of chemical compounds |
02/17/2011 | WO2011018446A1 Insect-based ex vivo model for testing blood-brain barrier penetration and method for exposing insect brain to chemical compounds |
02/17/2011 | WO2011018421A1 Novel screening strategies for the identification of binders |
02/17/2011 | WO2011018288A1 Means and methods for diagnosingthyroid disorders |
02/17/2011 | WO2011018241A1 Methods for the identification and characterization of hdac interacting compounds |
02/17/2011 | WO2011018184A1 Fluorescence-based imaging and analysis of cells and cellular components using lipophilic dyes with improved specificity, spectral properties and photostability |
02/17/2011 | WO2011018172A1 Test element for analyzing a body fluid |
02/17/2011 | WO2011018149A1 Test element for analyzing a body fluid |
02/17/2011 | WO2011018107A1 Method and device for measuring physical characteristics of biological samples |
02/17/2011 | WO2011018090A1 Predictive marker for hydroxyurea resistance |
02/17/2011 | WO2011018067A1 Method for separating particles and/or cells having 2 and more surface specificities |
02/17/2011 | WO2011017959A1 Fruit maturity determination method and system |
02/17/2011 | WO2011017916A1 Solvatochromic functional monomer and use thereof for chemosensing by solvatochromic molecular imprinting |
02/17/2011 | WO2011017911A1 Detection device and method of using the same |
02/17/2011 | WO2011017792A1 Extractive analytical method for tannins determination on raw materials and plant products |